The efficiency of endocrine therapy for tumors is limited by the development of hormone resistance and progression of tumor cells to hormone-independent phenotype. Among these tumors – breast cancers, for which hormone therapy is one of the most common and effective methods of treatment, but only in cases, when the tumors retain their hormonal dependence. The mechanism of hormonal independence was found to be based on the fundamental properties of cancer cell including both downregulation of specific hormone receptors, and affecting of intracellular signalling, particularly – estrogen-independent growth signaling pathways. However, the role of the intercellular interactions in the progression of hormonal resistance is still unclear.We hypot...
Endocrine resistance in breast cancer remains a major clinical problem and is caused by crosstalk me...
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors...
De novo insensitivity and acquired resistance to the selective oestrogen receptor modulator tamoxife...
The efficiency of endocrine therapy for tumors is limited by the development of hormone resistance a...
We have isolated a series of sublines of the hormone-dependent MCF-7 human breast cancer cell line a...
Abstract The interplay of positive and negative interactions between drug-sensitive and resistant ce...
The progression of breast tumors to steroid-autonomous and antiestrogen-resistant phenotypes confoun...
We have established and characterized a series of variant cell lines in which to identify the critic...
Breast cancer is the most prevalent form of cancer in women and accounts for 519,000 annual deaths (...
Development of acquired resistance against antiestrogen treatment is a serious problem in human brea...
Many breast tumors appear to follow a predictable clinical pattern, being initially responsive to en...
Human mammary carcinoma cell lines (MCF‐7) were analysed for their hormone sensitivity before and af...
Many estrogen receptor-positive breast cancer patients initially respond to treatment with antihormo...
We have previously demonstrated that, following acquisition of endocrine resistance, breast cancer c...
Growth of MCF7 McGrath human breast cancer cells (MCF7) under conditions of longterm oestrogen depri...
Endocrine resistance in breast cancer remains a major clinical problem and is caused by crosstalk me...
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors...
De novo insensitivity and acquired resistance to the selective oestrogen receptor modulator tamoxife...
The efficiency of endocrine therapy for tumors is limited by the development of hormone resistance a...
We have isolated a series of sublines of the hormone-dependent MCF-7 human breast cancer cell line a...
Abstract The interplay of positive and negative interactions between drug-sensitive and resistant ce...
The progression of breast tumors to steroid-autonomous and antiestrogen-resistant phenotypes confoun...
We have established and characterized a series of variant cell lines in which to identify the critic...
Breast cancer is the most prevalent form of cancer in women and accounts for 519,000 annual deaths (...
Development of acquired resistance against antiestrogen treatment is a serious problem in human brea...
Many breast tumors appear to follow a predictable clinical pattern, being initially responsive to en...
Human mammary carcinoma cell lines (MCF‐7) were analysed for their hormone sensitivity before and af...
Many estrogen receptor-positive breast cancer patients initially respond to treatment with antihormo...
We have previously demonstrated that, following acquisition of endocrine resistance, breast cancer c...
Growth of MCF7 McGrath human breast cancer cells (MCF7) under conditions of longterm oestrogen depri...
Endocrine resistance in breast cancer remains a major clinical problem and is caused by crosstalk me...
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors...
De novo insensitivity and acquired resistance to the selective oestrogen receptor modulator tamoxife...